Skip to main content

Table 1 Pathogenic variants VUS identified in our study

From: Breast cancer in West Africa: molecular analysis of BRCA genes in early-onset breast cancer patients in Burkina Faso

Gene

Location

HGSV nucleotide

HGSV protein

Number of carriers

dbSNP

Allele frequency

Allele frequency in Africa (gnomAD)

p value

All populations Frequency

ACMG criteria

Pathogenic variants

BRCA1

Exonic

c.5177_5180delGAAA

p.Arg1726Lysfs*3

1

rs80357975

0.98%

0.012%

0.01

0.0008%

PVS1, PP5, PM2, PM3

 

Exonic

c.4088C>G

p.Ser1363*

2

rs398122680

1.96%

0.006%

0.00003

0.0004%

PVS1, PP5, PM2, PM3

 

Intronic

c.4986+6T>C

p.(?)

2

rs80358086

1.96%

0%

0.00001

0.0004%

PP5, PM2, BP4

BRCA2

Exonic

c.6445_6446delAT

p.Ile2149*

1

rs80359592

0.98%

Not Reported

-

-

PVS1, PP5, PM2

 

Exonic

c.8009C>T

p.Ser2670Leu

1

rs80359035

0.98%

Not Reported

-

-

PP5, PM2, PM3

 

Exonic

c.6757_6758delCT

p.Leu2253Phefs*7

1

rs80359623

0.98%

0%

0.003

0.0004%

PVS1, PP5, PM2

VUS

BRCA1

Exonic

c.5348T>C

p.Met1783Thr

1

rs55808233

0.98%

0.17%

0.16

0.016%

PM1, PM2, PP3,PP5

BRCA2

Exonic

c.7504C>T

p.Arg2502Cys

1

rs55716624

0.98%

0.32%

0.28

0.033%

PM2, BP4

  1. Significant differences are reported in bold
  2. ACMG: American College of Medical Genetics